FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, namely to a medicinal agent, possessing antiviral and anti-inflammatory action and represents a soft dosage form. Pharmaceutical composition contains a therapeutically effective amount of hiporhamine and target additives. At the same time as a target additive is used an emulsion wax, with the following ratio of composition components, g: hiporhamine 0.45-05; emulsion wax 6.0-8.0; vaseline oil 8.0-10.0; glycerine 8.0-10.0; sorbic acid 0.2-0.3; purified water to 100,0.
EFFECT: therapeutic composition is made in the form of cream, possesses high bioavailability availability and stability during storage due to combination of components of the dosage form, sequence of their introduction.
4 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2538082C2 |
| PHARMACEUTICAL COMPOSITION HAVING ANTIMICROBIAL ACTION | 2015 |
|
RU2596500C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL ACTION | 2016 |
|
RU2621156C1 |
| AGENT FOR SUPERFICIAL MYCOSES TREATMENT | 2007 |
|
RU2337689C1 |
| HEALING CREAM WITH ANTI-INFLAMMATORY AND VENOTONIC ACTION | 2016 |
|
RU2630977C1 |
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| 4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
